Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Repare Therapeutics
Biotech
Repare nails down XenoTherapeutics buyout
After laying off staff and partnering away an asset, the precision oncology outfit has agreed to be acquired by nonprofit biotech XenoTherapeutics.
Darren Incorvaia
Nov 17, 2025 12:12pm
Repare finds suitor for PKMYT1 inhibitor in partner Debiopharm
Jul 16, 2025 5:38am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
Repare unveils scale of layoffs with 75% of staff, CMO departing
Feb 25, 2025 8:05am
Repare cans plans for phase 3 cancer combo trial
Jan 10, 2025 4:30am
Repare lays off 25% of staff as biotech halts preclinical R&D
Aug 29, 2024 6:36am
